Skip to content

Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism

Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04922892
Enrollment
200
Registered
2021-06-11
Start date
2021-06-01
Completion date
2028-05-31
Last updated
2021-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary Hyperparathyroidism;Parathyroidectomy

Keywords

Secondary Hyperparathyroidism;Parathyroidectomy;hemodialysis

Brief summary

Total parathyroidectomy with autotransplantation (TPTX+AT) and Total parathyr- oidectomy alone (TPTX) are the common surgical procedures.The purpose of the study was to compare the long-term benefits of surgery between the two groups.

Detailed description

The trial was performed as a nonconfirmatory randomized controlled pilot trial with 200 patients on long-term dialysis with otherwise uncontrollable SHPT to generate data on the rate of recurrent disease within a 5-year follow-up period after TPTX or TPTX+AT. Parathyroid hormone (PTH) and calcium levels, recurrent or persistent hyperparathyroidism, parathyroid reoperations, morbidity, and mortality were evaluated during a 5-year follow-up.

Interventions

PROCEDUREParathyroidectomy

Total Parathyroidectomy With Autotransplantation or Total Parathyroidectomy Alone

Sponsors

The Second Hospital of Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Severe renal secondary hyperparathyroidism

Exclusion criteria

Patients with diabetes a history of chronic inflammatory disease a history of malignant tumor a history of kidney transplantation a history of neck surgery a history of alcohol abuse a history of drug abuse inability to cooperate with the participants refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
the rate of recurrent60 monthsthe rate of recurrent

Countries

China

Contacts

Primary ContactMingxia XIONG, Ph.D
xiongmingxia@njmu.edu.cn13951880995

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026